Acute graft versus host disease due to T lymphocytes recognizing a single HLA-DPB1*0501 mismatch

Journal of Clinical Investigation

Volumn 98, Issue 1, 1996, Pages 100-107

  Gaschet, Joëlle ^a   Lim, Annick ^b   Liem, Linda ^c   Vivien, Régine ^a   Hallet, Marie Martine ^a   Harousseau, Jean Luc ^d   Even, Jos ^b   Goulmy, Els ^c   Bonneville, Marc ^a   Milpied, Noël ^d   Vié, Henri ^a  

^a INSERM   (France)

^b INSTITUT PASTEUR   (France)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d NANTES UNIVERSITY HOSPITAL   (France)

Author keywords

clone; HLA DP; skin; specificity; T lymphocytes

Indexed keywords

HLA DP ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; T LYMPHOCYTE RECEPTOR;

ADULT; ANTIGEN SPECIFICITY; ARTICLE; BONE MARROW TRANSPLANTATION; CASE REPORT; FEMALE; GRAFT VERSUS HOST REACTION; HLA MATCHING; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPHOCYTIC INFILTRATION; PRIORITY JOURNAL; SKIN BIOPSY; T LYMPHOCYTE;

EID: 8944259894     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI118753     Document Type: Article

References (29)

1. Ferrara, J.L.M., and H.L. Deeg. 1991. Graft-versus-host disease. N. Engl. J. Med. 324:667-674.
2. Beatty, P.G., J.A. Hansen, G.M. Longton, E.D. Thomas, J.E. Sanders, P.J. Martin, S.I. Bearman, C. Anasetti, E.W. Petersdorf, E.M. Mickelson, et al. 1991. Marrow transplantation from HLA-matched unrelated donor for hematologivc malignancies. Transplantation (Baltimore). 51:443-447.
3. Ash, R.C., J.T. Casper, C.R. Chitambar, R. Hansen, N. Bunin, R.L. Truitt, C. Lawton, K. Murray, J. Hunter, L.A. Baxter-Lowe, et al. 1990. Successful allogeneic transplantation of T-cell depleted bone marrow from closely HLA-matched unrelated donors. N. Engl. J. Med. 322:485-494.
4. Anasetti, C., P.G. Beatty, R. Storb, P.J. Martin, M. Mori, J.E. Sanders, E.D. Thomas, and J.A. Hansen. 1990. Effect of HLA incompatibility on graft-versus-host disease, relapse and survival after marrow transplantation for patients with leukemia or lymphoma. Hum. Immunol. 29:79-87.
5. Beatty, P.G., R.A. Clift, E.M. Mickelson, B. Nisperos, N. Flournoy, P.J. Marin, J.E. Sanders, R. Storb, E.D. Thomas, and J.A. Hansen. 1985. Marrow transplantation from related donors other than HLA-identical siblings. N. Engl. J. Med. 313:765-771.
6. Hansen, J.A., C. Anasetti, P.G. Beatty, P.J. Martin, J.E. Sanders, R. Storb, and E.D. Thomas. 1990. Treatment of leukemia by marrow transplantation from HLA-incompatible donors. Effect of HLA-disparity on GVHD, relapse and survival. Bone Marrow Transplant. 6:108-111.
7. Storb, R., H.J. Deeg, J. Whitehead, F. Appelbaum, P.B. Beatty, W. Bensinger, C.D. Buckner, R. Clift, K. Doney, V. Farewell, J.A. Hansen, et al. 1986. Methotrexate and cyclosporine compared with cyclosporine alone for the treatment of acute graft versus host disease after marrow transplantation for leukemia. N. Engl. J Med. 314:729-735.
8. Beatty, P.G., C. Anasetti, J.A. Hanse, G.M. Longton, J.E. Sanders, P.J. Marin, E.M. Mickelson, S.Y. Choo, E.W. Petersdorf, M.S. Pepe, F.R. Appelbaum, et al. 1993. Marrow transplantation from unrelated donors for treatment of hematologic malignancies: effect of mismatching of one HLA locus. Blood. 81:249-253.
9. Moreau, P., and A. Cesbron. 1994. HLA-DP and allogeneic bone marrow transplantation. Bone Marrow Transplant. 13:675-681.
10. Petersdorf, E.W., A.G. Smith, E.M. Mickelson, G.M. Longton, C. Anasetti, S.Y. Choo, P.J. Martin, and J.A. Hansen. 1993. The role of HLA-DPB1 disparity in the development of acute graft-versus-host disease following unrelated bone marrow transplantation. Blood. 81:1923-1932.
11. Gaschet, J., B. Mahe, N. Milpied, M.C. Devilder, B. Dreno, J.D. Bignon, F. Davodeau, M.M. Hallet, M. Bonneville, and H. Vié. 1993. Specificity of T cell invading the skin during acute graft versus host disease after semi allogeneic bone marrow transplantation. J. Clin. Invest. 91:12-20.
12. Gaschet, J., M.A. Trevino, M. Cherel, R. Vivien, A.G. Sahuquillo, M.M. Hallet, M. Bonneville, J.L. Harrousseau, R. Bragado, N. Milpied, and H. Vié. 1996. HLA-target antigens and TCR diversity of activated T cells invading the skin during acute graft versus host disease. Blood. 87:2345-2353.
13. Gaschet, J., C. Denis, N. Milpied, M.M. Hallet, F. Davodeau, A. Necker, F. Romagne, M. Bonneville, and H. Vié. 1995. Analysis of T-cell receptor Vb expression among Va subsets. Evidence for tight regulation of the combinatorial diversity. Ann. NY Acad. Sci. 756:84-86.
14. Even, J., A. Lim, I. Puisieux, L. Ferradini, P.Y. Dietrich, A.Toubert, T. Hercend, F. Triebel, C. Pannetier, and P. Kourilsky. 1996. T cell repertoire in healthy and diseased human tissues analysed by T cell receptor b chain CDR3 size determination: evidence for clonal expansions in tumors and inflammatory diseases. Res. Immunol. 146:65-80.
15. Pannetier, C., S. Delassus, S. Darche, C. Saucier, and P. Koutilsky. 1993. Quantitative titration of nucleic acids by enzymatic amplification reactions run to saturation. Nucleic Acids Res. 21:577-583.
16. Pannetier, C., M. Cochet, S. Darche, A. Casrouge, M. Zoller, and P. Kourilsky. 1993. The size of the CDR3 hypervariable regions of the murine T cell receptor b chain vary as a function of the recombined germline segments. Proc. Natl. Acad. Sci. USA. 90:4319-4323.
17. Dietrich, P.Y., A. Caignard, A. Diu, C. Genevee, J.L. Pico, M. Henry-Amar, E. Angevin, F. Triebel, and T. Hercend. 1990. Analysis of T cell receptor variability in transplanted patients with graft-versus-host disease. Blood. 80: 2419-2424.
18. Dietrich, P.Y., A. Caignard, Y. Lim Chung, J.L. Pico, C. Pannetier, P. Kourilsky, T. Hercent, and F. Triebel. 1994. In vivo clonal amplification at time of acute graft-versus-host disease. Blood. 84:2815-2820.
19. Goulmy, E., R. Shipper, J. Pool, E. Blokland, J.H.F. Falkenburg, J. Vossen, A. Gratwohl, G.B Vogelsang, H.C. van Houwelingen, and J.J. van Rood. 1996. Mismatches of minor histocompatibility antigens between HLA-identical donors and recipients and the development of graft-versus-host disease after bone marrow transplantation. N. Engl. J. Med. 334:281-285.
20. Martin, P.J. 1991. Increased disparity for minor histocompatibility antigens as a potential cause of increased GVHD risk in marrow transplantation from unrelated donors compared with related donors. Bone Marrow Transplant. 8:217-225.
21. van Lochem, E.G., A. Bakker, S. Snijder, M. Aarts, G.C. de Gast, and E. Goulmy. 1995 Epstein-Barr virus infection abrogates the stimulatory capacity of B cells to a major histocompatibility complex class II-restricted proliferative T cell clone. Hum. Immunol. 42(2):137-144.
22. Apperley, J.F., F.R. Mauro, J.M. Goldman, W. Gregory, C.K. Arthur, J. Hawks, W. Arcese, G. Papa, F. Mandelli, D. Wardle, et al. 1988. Bone marrow transplantation for chronic myelogenous leukemia in first chronic phase: Importance of a graft-versus-leukemia effect. Br. J. Haematol. 69:239-246.
23. Weiden, P.L., K.M. Sullivan, N. Flournoy, R. Storb, and E.D. Thomas. 1981. The Seattle Marrow Transplant Team: antileukemic effect of chronic graft-versus-host disease. Contribution for improved survival after allogeneic marrow transplantation. N. Engl. J. Med. 304:1529-1532.
24. Horowitz, M.M., R.P. Gale, P.M. Sondel, J.M. Goldman, J. Kersey, H.J. Kolb, A.A. Rimm, O. Ringden, C. Rozman, B. Speck, et al. 1990. Graft-versus-leukemia reaction after bone marrow transplantation. Blood. 75:555-562.
25. Kolb, H.J., A. Schattenberg, J.M. Goldman, B. Hertenstein, N. Jacobsen, W. Arcese, P. Ljungman, A. Ferrant, L. Veronck, D. Niederwieser, et al. 1995. For the European group for blood and marrow transplantation. Graft-versus-leukemia effect of donor lymphocyte transfusion in marrow grafted recipients. Blood. 86:2041-2050.
26. MacKinnon, S., E.B. Papadopoulos, M.H. Carabasi, L. Reich, N.H. Collins, F. Boulal, H. Castro-Malaspina, B.H. Childs, A.P. Gillio, N.A. Kernan, et al. 1995. Adoptive immunotherapy evaluating escalating doses of donor leukocytes for relapse of chronic myeloid leukemia after bone marrow transplantation: separation of graft-versus-leukemia responses from graft-versus-host disease. Blood. 86:1261-1268.
27. Tiberghien, P., C.W. Reynolds, J. Keller, S. Spence, M. Deschaseaux, J.M. Certoux, E. Contassot, W.J. Murphy, R. Lyons, Y. Chiang, et al. 1994. Ganciclovir treatment of herpes simplex thymidine kinase-transduced primary T lymphocytes: an approach for specific in vivo donor T-cell depletion after bone marrow transplantation. Blood. 84:1333-1341.
28. Borelli, E., R. Heyman, M. Hsi, and R.M. Evans. 1988. Targeting of an inducible toxic phenotype in anomal cells. Proc. Nat. Acad. Sci. USA. 85:7572-7576.
29. Gallot, G., M.M.H. Hallet, J. Gashet, J.M. Moreau, R. Vivien, M. Bonneville, N. Milpied, and H. Vié. 1996. Human HLA-specific T cell clone with stable expression of a suicide gene: a possible tool to drive and control a GVH-GVL reaction. Blood. In press.